| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM198604173141601 |
| P698 | PubMed publication ID | 3515182 |
| P2093 | author name string | Modan M | |
| Gafni J | |||
| Sohar E | |||
| Cabili S | |||
| Pras M | |||
| Zemer D | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | (S)-(−)-colchicine | Q326224 |
| P304 | page(s) | 1001-1005 | |
| P577 | publication date | 1986-04-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever | |
| P478 | volume | 314 |
| Q89686028 | A Case of Familial Mediterranean Fever without Fever |
| Q38163822 | A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin |
| Q40528736 | A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis |
| Q35638094 | A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients |
| Q55389099 | A rare cause of fever in an adult: a case of familial Mediterranean fever. |
| Q40345965 | AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients |
| Q40604912 | Abdominal CT findings in nephropathic amyloidosis of familial Mediterranean fever |
| Q40215842 | Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I. |
| Q41690862 | Amyloid A amyloidosis with subcutaneous drug abuse |
| Q38305339 | Amyloid A amyloidosis: frequently neglected renal disease in injecting drug users |
| Q68128411 | Amyloid and amyloidosis |
| Q71791723 | Amyloidosis |
| Q77061406 | Amyloidosis |
| Q36692876 | Amyloidosis and the lung. |
| Q40697904 | Amyloidosis in children |
| Q41222580 | Amyloidosis in rheumatic diseases |
| Q34115528 | Amyloidosis of familial mediterranean fever and the MEFV gene |
| Q34722948 | Amyloidosis: prognosis and treatment |
| Q40079604 | Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Q40771317 | Ankylosing spondylitis. An unusual manifestation of familial Mediterranean fever. Report of a case complicated by amyloidosis and polyneuropathy |
| Q37874985 | Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature. |
| Q58288359 | Apolipoprotein E genotypes in AA and AL amyloidoses |
| Q42375802 | Approach to recurrent fever in childhood |
| Q30481548 | Arterial distensibility in chronic inflammatory rheumatic disorders |
| Q38225736 | Assessment of renal involvement in patients with familial Mediterranean fever: a clinical study from Ardabil, Iran |
| Q40214013 | Assessment of sleep problems in children with familial Mediterranean fever |
| Q35558406 | Autoinflammation: translating mechanism to therapy |
| Q37048084 | Autoinflammatory Skin Disorders: The Inflammasomme in Focus |
| Q38715104 | Autoinflammatory Syndromes in Children |
| Q37128189 | Autoinflammatory diseases: an update of clinical and genetic aspects |
| Q40664668 | Autosomal dominant familial Mediterranean fever--like syndrome |
| Q40791565 | Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis |
| Q40621738 | Behçet's disease in Familial Mediterranean fever: characterization of the association between the two diseases |
| Q40493010 | Biologic and clinical advances in familial Mediterranean fever |
| Q37077564 | Biological treatments: new weapons in the management of monogenic autoinflammatory disorders |
| Q49950020 | Canakinumab treatment in children with familial Mediterranean fever: report from a single center |
| Q40203722 | Cardiac autonomic functions in children with familial Mediterranean fever |
| Q50100074 | Cardiac disease in familial Mediterranean fever |
| Q72502462 | Cardiotoxicity of colchicine in the rat |
| Q37326180 | Case report: recurrent abdominal symptoms in a child with panhypopituitarism - there is always a differential |
| Q52659306 | Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma. |
| Q77797493 | Chronic recurrent abdominal pain |
| Q24300638 | Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations |
| Q64361014 | Clinical and therapeutic aspects of AA amyloidosis |
| Q40729127 | Colchicine Treatment in Conception and Pregnancy: Two Hundred Thirty‐one Pregnancies in Patients With Familial Mediterranean Fever |
| Q38560160 | Colchicine as an anti-inflammatory and cardioprotective agent. |
| Q27863445 | Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation |
| Q77647297 | Colchicine in dermatology |
| Q40709737 | Colchicine in the treatment of AA and AL amyloidosis |
| Q72285386 | Colchicine induced remission in amyloid nephrotic syndrome |
| Q36948153 | Colchicine intoxication: Clinical pharmacology, risk factors, features, and management |
| Q37768420 | Colchicine poisoning: the dark side of an ancient drug |
| Q68326147 | Colchicine therapy of the renal amyloidosis of ulcerative colitis |
| Q37772327 | Colchicine--expanding horizons |
| Q38554404 | Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori |
| Q73040007 | Colchicine-induced elevation of tissue metallothionein contents is mediated by inflammation-independent serum factor |
| Q40042238 | Colchicine: an ancient drug with novel applications |
| Q40044427 | Cold Exposure Related Fever with an Mediterranean Fever (MEFV) Gene Mutation |
| Q97521410 | Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide |
| Q40846581 | De novo amyloidosis in a renal allograft: a case report and review of the literature |
| Q40370686 | Depression and anxiety in children and adolescents with familial Mediterranean fever |
| Q49324798 | Duodenal amyloidosis secondary to ulcerative colitis |
| Q93702730 | EDITOR'S QUIZ: GI SNAPSHOT |
| Q26775286 | EULAR recommendations for the management of familial Mediterranean fever |
| Q40459503 | Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. |
| Q36027314 | Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever |
| Q38674665 | Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review |
| Q47295095 | Efficacy of anakinra in a patient with systemic amyloidosis presented with amyloidoma |
| Q43188930 | Efficacy of colchicine in familial Mediterranean fever is well established |
| Q40561121 | Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever |
| Q81311754 | Eprodisate slows the progression of renal disease in patients with AA amyloidosis |
| Q43890792 | Etiology of chronic renal failure in Turkish children |
| Q40305855 | Evaluation of the mean platelet volume in children with familial Mediterranean fever |
| Q44410422 | Exocytotic “constipation” is a mechanism of tubulin/lysosomal interaction in colchicine myopathy |
| Q92796536 | Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans |
| Q37716794 | Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management |
| Q40599060 | Familial Mediterranean fever |
| Q38658722 | Familial Mediterranean fever (recurrent hereditary polyserositis) in children: analysis of 88 cases |
| Q40552834 | Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. |
| Q40499439 | Familial Mediterranean fever among the autoimmune diseases |
| Q40714538 | Familial Mediterranean fever and amyloidosis in children |
| Q35143035 | Familial Mediterranean fever and its implications for fertility and pregnancy. |
| Q40364188 | Familial Mediterranean fever gene mutation frequencies and genotype-phenotype correlations in the Aegean region of Turkey |
| Q40268824 | Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk |
| Q40277153 | Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population |
| Q38599628 | Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase |
| Q40431348 | Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations |
| Q35281058 | Familial Mediterranean fever in which Crohn's disease was suspected: a case report |
| Q40567503 | Familial Mediterranean fever is no longer a rare disease in Italy |
| Q24799138 | Familial Mediterranean fever, inflammation and nephrotic syndrome: fibrillary glomerulopathy and the M680I missense mutation |
| Q36519027 | Familial Mediterranean fever--an update |
| Q40722419 | Familial Mediterranean fever-associated amyloidosis |
| Q53649569 | Familial Mediterranean fever. |
| Q34073432 | Familial Mediterranean fever. A review of the disease and clinical and laboratory findings in 105 patients |
| Q40627280 | Familial Mediterranean fever. New aspects with respect to molecular genetics and pathogenesis revealed in three case reports |
| Q40583682 | Familial Mediterranean fever: the segregation of four different mutations in 13 individuals from one inbred family: genotype-phenotype correlation and intrafamilial variability. |
| Q40161734 | Fever of unknown origin in a haemodialysis patient: a late diagnosis requiring a novel treatment |
| Q40499431 | From familial Mediterranean fever to amyloidosis |
| Q35019675 | Genetic clues to understanding periodic fevers, and possible therapies |
| Q40252367 | Genetic fever syndromes. Hereditary recurrent (periodic) fever syndromes |
| Q33678804 | Genotypic diagnosis of familial Mediterranean fever (FMF) using new microsatellite markers: example of two extensive non-Ashkenazi Jewish pedigrees |
| Q41702939 | Glucocorticoids in Alzheimer's disease. The story so far. |
| Q28243289 | Hereditary auto-inflammatory disorders and biologics |
| Q40521835 | Hereditary intermittant fever |
| Q51288792 | How nature preserves fetuses. |
| Q40783483 | Hyper-IGD syndrome: a new case treated with colchicine |
| Q34262561 | IL-1 blockade in autoinflammatory syndromes |
| Q38074355 | IL-1β biological treatment of familial Mediterranean fever. |
| Q34146734 | Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever |
| Q40368852 | Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome |
| Q49053424 | Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory Disease |
| Q41167374 | Inflammation and Alzheimer disease |
| Q24187197 | Interventions for reducing inflammation in familial Mediterranean fever |
| Q57688726 | Interventions for reducing inflammation in familial Mediterranean fever |
| Q33514820 | Involvement of the modifier gene of a human Mendelian disorder in a negative selection process |
| Q40241668 | Is colchicine therapy effective in all patients with secondary amyloidosis? |
| Q57588203 | Late presentation of familial Mediterranean fever associated with P369S/R408Q variant in the MEFV gene |
| Q40650393 | Light chain deposition disease complicating familial Mediterranean fever |
| Q71380967 | Localization of the familial Mediterranean fever gene (FMF) to a 250-kb interval in non-Ashkenazi Jewish founder haplotypes. The French FMF Consortium |
| Q40761955 | Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis). |
| Q40746167 | Long-term colchicine treatment in children with familial mediterranean fever |
| Q40073378 | Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study. |
| Q40553743 | Low serum apolipoprotein AI levels in amyloidosis related to familial Mediterranean fever |
| Q40618094 | MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? |
| Q34390765 | MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications |
| Q33967153 | Mapping of the Familial Mediterranean Fever Gene to Chromosome 16 |
| Q40394950 | Mean platelet volume in children with familial Mediterranean fever |
| Q36041225 | Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling |
| Q39301708 | Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient |
| Q37466515 | Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation |
| Q37299354 | Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues |
| Q64361152 | Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis |
| Q37068967 | Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents |
| Q33903590 | Neutrophils: molecules, functions and pathophysiological aspects |
| Q40740152 | Normal renin-aldosterone-insulin and potassium interrelationship in FMF patients and amyloid nephropathy |
| Q88990365 | Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases |
| Q38122566 | Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics |
| Q40525461 | Once-daily use of colchicine in children with familial Mediterranean fever |
| Q92543214 | Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series |
| Q34102054 | P wave dispersion and QT dispersion in adult Turkish migrants with familial mediterranean fever living in Germany |
| Q40556454 | Periodic fevers: from genetics to clinical medicine |
| Q40545793 | Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard |
| Q40230211 | Pregnancy outcome of five patients with renal amyloidosis regarding familial Mediterranean fever |
| Q72166359 | Prevention of recurrent aphthous stomatitis with colchicine: an open trial |
| Q40919522 | Primary (AL) amyloidosis |
| Q35856572 | Primary amyloidosis A. Immunohistochemical and biochemical characterization |
| Q40473433 | Pulmonary amyloidosis in familial Mediterranean fever. |
| Q40745020 | Pulmonary hypertension and familial Mediterranean fever: a previously unrecognized association |
| Q30489231 | Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants |
| Q40147075 | Pyrin-PSTPIP1 colocalises at the leading edge during cell migration |
| Q37468460 | Recurrent febrile syndromes: what a rheumatologist needs to know |
| Q43172636 | Recurrent hereditary polyserositis |
| Q37848210 | Renal amyloidosis in children |
| Q38661322 | Renal replacement therapy in multiple myeloma and systemic amyloidosis |
| Q70499049 | Renal replacement therapy in multiple myeloma and systemic amyloidosis |
| Q69922381 | Renal transplantation for dialysis arthropathy |
| Q40779017 | Renal transplantation in amyloid nephropathy |
| Q40236792 | Retrospective evaluation of pregnancy outcomes in women with familial Mediterranean fever. |
| Q77803126 | Rheumatologic manifestations of gastrointestinal diseases |
| Q40183920 | Risk factors for AA amyloidosis in Germany |
| Q40170055 | Risk factors for subclinical inflammation in children with Familial Mediterranean fever |
| Q24645278 | Safety of colchicine therapy during pregnancy |
| Q40558606 | Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis |
| Q33624218 | Serum concentration and urinary excretion of beta 2-microglobulin and microalbuminuria in familial Mediterranean fever |
| Q33560644 | Severe myalgia in familial Mediterranean fever: clinical and ultrastructural aspects |
| Q37872608 | Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). |
| Q40737835 | Spectrum of renal involvement in familial Mediterranean fever |
| Q40607006 | Spontaneous regression of bilateral surrenal haematoma and subclinical hypoaldosteronism in a patient with renal amyloidosis secondary to Familial Mediterranean Fever |
| Q40470996 | Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases. |
| Q40172573 | Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever |
| Q48574893 | Suppression of A beta-induced monocyte neurotoxicity by antiinflammatory compounds |
| Q36750220 | Systemic amyloidosis--three illustrative cases |
| Q35613120 | Temporomandibular arthritis in familial Mediterranean fever |
| Q40729131 | The Effect of Pregnancy on Renal Function in Amyloidosis of Familial Mediterranean Fever |
| Q97518819 | The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review |
| Q35209808 | The arthritis of familial mediterranean fever |
| Q36940783 | The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever. |
| Q40660571 | The changing face of familial Mediterranean fever |
| Q40282424 | The effect of colchicine on pyrin and pyrin interacting proteins |
| Q46982259 | The effect of colchicine on the peritoneal membrane |
| Q34039381 | The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever |
| Q24291475 | The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments |
| Q36981046 | The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach |
| Q34430168 | The therapeutic potential of interleukin-6 hyperagonists and antagonists |
| Q40919503 | Therapy of amyloid diseases |
| Q34714963 | Thoracic and lung involvement in familial Mediterranean fever (FMF). |
| Q70244867 | Toxic myopathies |
| Q64092000 | Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine |
| Q67910197 | Treatment with Intravenous Colchicine |
| Q40623410 | Treatments for amyloidosis beyond symptomatic care |
| Q43860892 | Tumour necrosis factor in familial Mediterranean fever |
| Q40724235 | Ultrasound and MRI findings in a case of childhood amyloid goiter |
| Q40625745 | Unifying features of systemic and cerebral amyloidosis |
| Q26749573 | Update on Pyrin Functions and Mechanisms of Familial Mediterranean Fever |
| Q40561366 | Urinary glycosaminoglycans in the course of familial Mediterranean fever |
| Q34315584 | Usefulness and significance of the concept of leukoaraiosis in the study of dementia |
| Q38681895 | What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review |
| Q40441761 | Which statin should be used together with colchicine? Clinical experience in three patients with nephrotic syndrome due to AA type amyloidosis |
| Q77396642 | [AA amyloidosis complicating sarcoidosis] |
| Q77421317 | [Genetic diagnosis of periodic disease] |
| Q80652900 | [Primary localized amyloidosis of glans penis. A new case and review of the literature] |
| Q42375820 | Approche à la fièvre récurrente de l’enfant |
Search more.